Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ABCA2,ATP-binding cassette sub-family A member 2,18884,64,2.04 [1.19-3.49],0.0092032626267219
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACE,Angiotensin-converting enzyme,19567,68,2.38 [1.14-5.00],0.0214535077671339
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACP6,Lysophosphatidic acid phosphatase type 6,22595,81,0.76 [0.59-0.97],0.0281135297568766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACSL1,Long-chain-fatty-acid--CoA ligase 1,18884,64,1.57 [1.01-2.44],0.0457336179797471
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACTA2,"Actin, aortic smooth muscle",22040,77,1.67 [1.22-2.28],0.0012256256075629
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACY1,Aminoacylase-1,22453,81,1.45 [1.06-1.96],0.0181089298055181
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,18884,64,1.54 [1.05-2.26],0.0262829086749845
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADA,Adenosine deaminase,22669,80,1.76 [1.11-2.79],0.0161986562012453
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADA2,Adenosine deaminase 2,22343,80,2.22 [1.49-3.32],0.0001020531344463
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADAMTSL2,ADAMTS-like protein 2,19568,68,2.09 [1.13-3.85],0.0190518039610589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRE1,Adhesion G protein-coupled receptor E1,19459,66,1.56 [1.06-2.30],0.024296106120366
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADGRF5,Adhesion G protein-coupled receptor F5,19554,67,2.41 [1.09-5.35],0.0305756924154886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADH1B,All-trans-retinol dehydrogenase,19150,68,1.50 [1.14-1.96],0.0035482618076423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,22040,77,1.30 [1.03-1.65],0.0287436965462825
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ADRA2A,Alpha-2A adrenergic receptor,18884,64,0.59 [0.35-0.98],0.0409246023416972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AGXT,Serine--pyruvate aminotransferase,22453,81,1.36 [1.08-1.73],0.0101504348560909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ALDH1A1,Retinal dehydrogenase 1,22481,80,1.50 [1.08-2.07],0.0144362791984402
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,AMIGO2,Amphoterin-induced protein 2,22343,78,3.11 [1.35-7.17],0.007790790623077
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANG,Angiogenin,22425,80,1.73 [1.01-2.95],0.0444698301284522
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPT2,Angiopoietin-2,22632,81,1.67 [1.02-2.73],0.0406921950332547
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL1,Angiopoietin-related protein 1,22135,76,2.09 [1.05-4.16],0.0354438733726936
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL2,Angiopoietin-related protein 2,22477,81,1.64 [1.02-2.64],0.0418960488774241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANGPTL4,Angiopoietin-related protein 4,22511,81,2.08 [1.36-3.18],0.0007532545043909
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANPEP,Aminopeptidase N,22541,80,2.22 [1.18-4.18],0.0133404721696956
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ANXA10,Annexin A10,21936,76,1.23 [1.00-1.52],0.0468135058850049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARG2,"Arginase-2, mitochondrial",19460,68,1.57 [1.08-2.29],0.0183809123105725
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARHGEF5,Rho guanine nucleotide exchange factor 5,18910,64,1.43 [1.10-1.85],0.006833915435499
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ARSA,Arylsulfatase A,22481,80,1.54 [1.04-2.26],0.029539919153217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATP1B4,Protein ATP1B4,18853,65,1.66 [1.11-2.49],0.0135330201444655
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATRAID,All-trans retinoic acid-induced differentiation factor,19459,66,1.83 [1.14-2.94],0.0117707075183025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATRN,"Attractin, Isoform 2",19587,69,3.50 [1.02-11.96],0.0457270709140994
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ATXN2,Ataxin-2,18910,64,1.21 [1.03-1.42],0.0181443602950473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,21953,75,1.46 [1.10-1.93],0.0093705399631734
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BATF,Basic leucine zipper transcriptional factor ATF-like,19029,66,1.31 [1.08-1.58],0.0054085478156769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BCAM,Basal cell adhesion molecule,22481,80,2.04 [1.02-4.08],0.0439219607945851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BST2,Bone marrow stromal antigen 2,22637,81,1.61 [1.21-2.16],0.0011869670990593
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,BTN3A2,Butyrophilin subfamily 3 member A2,22392,81,1.65 [1.11-2.45],0.013530810626223
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QA,Complement C1q subcomponent subunit A,22564,79,2.80 [1.21-6.48],0.0161536233586731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,22574,80,2.13 [1.47-3.07],5.538190508791646e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,19150,68,2.26 [1.23-4.18],0.0088238452298028
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CA9,Carbonic anhydrase 9,22632,81,1.61 [1.13-2.30],0.0086671760232186
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CANT1,Soluble calcium-activated nucleotidase 1,22374,81,3.24 [1.28-8.20],0.0131066671585526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CBLN1,Cerebellin-1,18910,64,1.24 [1.04-1.49],0.0169363350599082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCL14,C-C motif chemokine 14,22425,80,1.55 [1.01-2.36],0.0437465723712241
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN2,CCN family member 2,22420,80,1.51 [1.07-2.14],0.0199594418817295
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CCN4,CCN family member 4,22632,81,1.75 [1.13-2.69],0.0113954999277824
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD14,Monocyte differentiation antigen CD14,22056,78,1.81 [1.16-2.82],0.0091688408239259
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD163,Scavenger receptor cysteine-rich type 1 protein M130,22574,80,1.84 [1.20-2.82],0.0048478821821058
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD2,T-cell surface antigen CD2,18884,64,1.50 [1.02-2.20],0.0377240315942129
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD244,Natural killer cell receptor 2B4,22669,80,2.13 [1.07-4.25],0.0312325112293127
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD34,Hematopoietic progenitor cell antigen CD34,22573,81,0.36 [0.16-0.82],0.0147349175421416
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD3G,T-cell surface glycoprotein CD3 gamma chain,18976,67,0.53 [0.32-0.86],0.0105919226257378
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD46,Membrane cofactor protein,22351,80,2.04 [1.13-3.69],0.018082506316769
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD59,CD59 glycoprotein,21681,77,2.17 [1.08-4.36],0.0295203996104549
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD5L,CD5 antigen-like,19476,69,1.77 [1.10-2.84],0.0177193565838538
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD72,B-cell differentiation antigen CD72,19150,68,1.75 [1.09-2.81],0.0208605262518093
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD80,T-lymphocyte activation antigen CD80,19554,67,1.98 [1.08-3.61],0.0271923462096991
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CD86,T-lymphocyte activation antigen CD86,19459,66,3.21 [1.59-6.50],0.0011840032094762
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDA,Cytidine deaminase,19509,67,1.54 [1.01-2.37],0.0471932124652995
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CDH2,Cadherin-2,22453,81,1.68 [1.00-2.81],0.0497794156844166
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CEP164,Centrosomal protein of 164 kDa,22021,77,1.27 [1.02-1.57],0.0300870408678505
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CES1,Liver carboxylesterase 1,22529,79,1.37 [1.10-1.71],0.0048085315032306
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,19567,68,1.91 [1.02-3.58],0.0421518770167082
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,21953,75,1.49 [1.13-1.96],0.0042656464884611
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",19518,67,1.77 [1.12-2.80],0.0152832483330542
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHGA,Chromogranin-A,19568,68,1.24 [1.01-1.53],0.0370503070803386
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CHIT1,Chitotriosidase-1,22556,79,1.27 [1.05-1.54],0.014045252981178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",22381,81,1.36 [1.01-1.84],0.0417087380083088
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CLTA,Clathrin light chain A,22040,77,1.49 [1.06-2.10],0.021609838186217
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CNTNAP2,Contactin-associated protein-like 2,22392,81,2.10 [1.40-3.15],0.0003361353480245
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL18A1,Collagen alpha-1(XVIII) chain,22572,78,3.01 [1.34-6.75],0.0074079409573359
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL3A1,Collagen alpha-1(III) chain,19568,68,2.69 [1.09-6.64],0.0318028095571155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,COL5A1,Collagen alpha-1(V) chain,19150,68,1.96 [1.18-3.25],0.0094202342027094
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CR1,Complement receptor type 1,19493,68,2.15 [1.15-4.01],0.016600529834417
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CR2,Complement receptor type 2,22574,80,1.54 [1.03-2.30],0.0350145186260135
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CREB3,Cyclic AMP-responsive element-binding protein 3,18853,65,1.52 [1.13-2.04],0.0060562091909588
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRH,Corticoliberin,21914,75,0.70 [0.54-0.90],0.005500072213328
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRIM1,Cysteine-rich motor neuron 1 protein,22549,81,2.72 [1.10-6.74],0.0303732631360091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRIP2,Cysteine-rich protein 2,22257,80,1.71 [1.19-2.46],0.0036732937144122
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRNN,Cornulin,21835,80,0.69 [0.53-0.90],0.0059953910417183
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CRTAP,Cartilage-associated protein,19029,66,0.49 [0.25-0.96],0.0370616589737662
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSF1R,Macrophage colony-stimulating factor 1 receptor,19567,68,2.66 [1.63-4.34],8.828790875869685e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CSPG4,Chondroitin sulfate proteoglycan 4,19568,68,2.95 [1.52-5.73],0.00135873122925
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CST3,Cystatin-C,22537,80,2.10 [1.15-3.83],0.0156376823961298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSO,Cathepsin O,22669,80,2.35 [1.33-4.13],0.0030849479539447
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CTSZ,Cathepsin Z,22512,80,2.15 [1.19-3.88],0.0112667637078076
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CXCL10,C-X-C motif chemokine 10,22549,81,1.30 [1.01-1.69],0.0445295716682042
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,CYB5A,Cytochrome b5,18853,65,1.48 [1.23-1.78],3.6787624201203846e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",22542,79,1.80 [1.03-3.14],0.0391741592350568
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCTPP1,dCTP pyrophosphatase 1,22453,81,1.82 [1.00-3.31],0.0488378378460098
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DCXR,L-xylulose reductase,22542,79,1.58 [1.12-2.24],0.0100453543902726
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DLL1,Delta-like protein 1,22542,79,1.90 [1.04-3.49],0.0367611316281071
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DNAJB8,DnaJ homolog subfamily B member 8,22040,77,1.32 [1.01-1.73],0.0397518952911091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPP6,Dipeptidyl aminopeptidase-like protein 6,22343,78,1.91 [1.08-3.39],0.0270680274101745
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DPY30,Protein dpy-30 homolog,22551,81,1.50 [1.14-1.97],0.0034120313132817
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,DSCAM,Down syndrome cell adhesion molecule,19512,65,2.15 [1.15-4.01],0.0162285246883473
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",19554,67,1.44 [1.11-1.89],0.0070607525815258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,22545,80,2.03 [1.13-3.68],0.0187240147799813
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,EGFLAM,Pikachurin,19459,66,2.10 [1.23-3.60],0.006874029329585
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ERMAP,Erythroid membrane-associated protein,18976,67,1.75 [1.07-2.86],0.0248295609047449
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,F9,Coagulation factor IX,22527,80,3.81 [1.37-10.61],0.0105601618338126
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FABP1,"Fatty acid-binding protein, liver",22445,81,1.25 [1.03-1.52],0.024668762063684
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM20A,Pseudokinase FAM20A,19554,67,2.10 [1.09-4.05],0.0269980491689776
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FAM3D,Protein FAM3D,19459,66,1.37 [1.04-1.80],0.0238867220811646
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FCRL2,Fc receptor-like protein 2,22554,79,1.40 [1.00-1.94],0.0478947066275441
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGF23,Fibroblast growth factor 23,22599,81,1.44 [1.08-1.91],0.0119128640019446
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFBP1,Fibroblast growth factor-binding protein 1,22542,79,0.52 [0.28-0.94],0.0310875802527016
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGFR2,Fibroblast growth factor receptor 2,22542,79,2.75 [1.19-6.32],0.0175316622999683
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FGL1,Fibrinogen-like protein 1,19567,68,1.69 [1.21-2.36],0.0018572986171716
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,22257,80,2.58 [1.42-4.69],0.0019201233697926
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FTCD,Formimidoyltransferase-cyclodeaminase,19476,67,1.32 [1.02-1.70],0.0336013296493605
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUCA1,Tissue alpha-L-fucosidase,22610,78,1.34 [1.01-1.77],0.0394174211448681
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUOM,Fucose mutarotase,19150,68,1.83 [1.33-2.52],0.0002163910625358
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FUS,RNA-binding protein FUS,21921,75,1.56 [1.01-2.41],0.044789212071285
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,FZD8,Frizzled-8,18910,64,1.53 [1.07-2.18],0.0186845571425396
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,22343,78,2.44 [1.23-4.83],0.0106117887660373
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GAST,Gastrin,19518,67,1.18 [1.03-1.36],0.0201861077038519
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GDF15,Growth/differentiation factor 15,22732,79,1.70 [1.18-2.45],0.0042625876733308
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GDNF,Glial cell line-derived neurotrophic factor,21936,76,1.70 [1.09-2.67],0.0203548036032318
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GFAP,Glial fibrillary acidic protein,21914,74,1.55 [1.05-2.30],0.0289997227740864
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GGT1,Glutathione hydrolase 1 proenzyme,22449,80,1.58 [1.13-2.23],0.0079064435242753
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GH2,Growth hormone variant,21953,75,1.15 [1.04-1.27],0.005601370725654
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIMAP8,GTPase IMAP family member 8,18853,65,1.49 [1.09-2.04],0.012790756441831
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GIPC2,PDZ domain-containing protein GIPC2,19518,67,1.96 [1.02-3.78],0.044846396327325
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPD1,Glycerol-3-phosphate dehydrogenase,19460,68,1.58 [1.08-2.33],0.0193269305556423
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPR101,Probable G-protein coupled receptor 101,18910,64,1.35 [1.01-1.80],0.0398102484158856
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GPRC5C,G-protein coupled receptor family C group 5 member C,19460,68,1.58 [1.16-2.16],0.0035538527973445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GRPEL1,"GrpE protein homolog 1, mitochondrial",22343,78,1.68 [1.27-2.21],0.000224190694523
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GSR,"Glutathione reductase, mitochondrial",19449,67,4.29 [1.74-10.56],0.0015479956328298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,19201,67,1.29 [1.01-1.63],0.0392850507389841
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,GZMA,Granzyme A,22669,80,1.82 [1.10-2.99],0.0187503222192735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HAO1,Hydroxyacid oxidase 1,22632,81,1.19 [1.03-1.38],0.0199713984975063
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HEG1,Protein HEG homolog 1,19150,68,2.64 [1.13-6.14],0.0244957634122771
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HIP1R,Huntingtin-interacting protein 1-related protein,19473,67,1.56 [1.14-2.13],0.00544470884356
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HJV,Hemojuvelin,19512,65,1.65 [1.18-2.31],0.0031541563014563
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HLA-DRA,"HLA class II histocompatibility antigen, DR alpha chain",22326,81,1.99 [1.26-3.15],0.0034139631967004
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HNMT,Histamine N-methyltransferase,22155,80,1.52 [1.01-2.28],0.0431012771088061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,19518,67,1.58 [1.10-2.25],0.0124911019363687
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,22308,80,2.00 [1.05-3.83],0.0353999274821713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,18971,66,2.00 [1.21-3.30],0.0067133775711176
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGFBP7,Insulin-like growth factor-binding protein 7,22732,79,2.11 [1.37-3.25],0.000648517686231
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IGSF8,Immunoglobulin superfamily member 8,22453,81,2.16 [1.27-3.67],0.0042713708079304
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL12RB1,Interleukin-12 receptor subunit beta-1,22021,77,2.07 [1.34-3.20],0.0011096991283367
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL18BP,Interleukin-18-binding protein,22574,80,1.80 [1.02-3.17],0.0439677984526787
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL1RAP,Interleukin-1 receptor accessory protein,22481,80,0.56 [0.34-0.89],0.0157011909710079
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL2,Interleukin-2,22021,77,1.74 [1.06-2.86],0.0295426440053607
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL20,Interleukin-20,22021,77,0.51 [0.30-0.88],0.0160683201641061
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL5,Interleukin-5,22021,77,1.14 [1.01-1.28],0.0315468686901433
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IL5RA,Interleukin-5 receptor subunit alpha,22392,81,1.41 [1.02-1.93],0.0349208999485437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,IMMT,MICOS complex subunit MIC60,19460,68,1.62 [1.10-2.39],0.0151728869656974
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,INHBB,Inhibin beta B chain,19150,68,1.64 [1.10-2.43],0.0148664191709062
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB1,Integrin beta-1,22463,80,2.75 [1.26-5.98],0.0108828438093893
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGB5,Integrin beta-5,22542,79,1.96 [1.25-3.09],0.0036088698986636
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITGBL1,Integrin beta-like protein 1,19568,68,1.72 [1.01-2.92],0.0456954296501789
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,22574,80,2.17 [1.28-3.70],0.0043251477372168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KCNIP4,Kv channel-interacting protein 4,21936,76,0.58 [0.34-1.00],0.0495557029842168
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,18853,65,1.27 [1.04-1.54],0.0172520315768676
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KITLG,Kit ligand,22453,81,0.48 [0.29-0.78],0.0034529399285354
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLK12,Kallikrein-12,21953,75,0.84 [0.73-0.97],0.0144164244598014
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KLRD1,Natural killer cells antigen CD94,22669,80,1.76 [1.17-2.64],0.0067692472225165
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,KRT18,"Keratin, type I cytoskeletal 18",22343,78,1.36 [1.09-1.69],0.0071254487503331
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LECT2,Leukocyte cell-derived chemotaxin-2,19554,67,1.57 [1.14-2.18],0.0064969101732498
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LEG1,Protein LEG1 homolog,18533,68,1.36 [1.01-1.84],0.0456712011029804
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGALS7_LGALS7B,Galectin-7,22358,81,1.49 [1.04-2.13],0.0308955591912985
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LGMN,Legumain,22549,81,1.70 [1.01-2.87],0.0473735016823474
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LIFR,Leukemia inhibitory factor receptor,22392,81,2.55 [1.17-5.54],0.0182305677697973
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,18884,64,1.52 [1.09-2.12],0.0130678728115431
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,22021,77,1.62 [1.07-2.47],0.0242535963675935
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LMNB2,Lamin-B2,19518,67,2.22 [1.08-4.53],0.0294012172962029
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LPO,Lactoperoxidase,21691,78,1.44 [1.06-1.96],0.0185288574263905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTBP2,Latent-transforming growth factor beta-binding protein 2,22732,79,2.36 [1.35-4.11],0.0025047947827752
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,LTBP3,Latent-transforming growth factor beta-binding protein 3,21953,75,1.47 [1.13-1.91],0.0038526447716887
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,22178,80,1.39 [1.06-1.84],0.0184684034217946
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MATN2,Matrilin-2,22479,81,2.01 [1.04-3.86],0.0367066239969872
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MDK,Midkine,22479,78,1.37 [1.01-1.87],0.044603311573022
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFAP4,Microfibril-associated glycoprotein 4,19150,68,2.55 [1.28-5.10],0.0080874196727731
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MFGE8,Lactadherin,22481,80,1.54 [1.00-2.36],0.0490738622799198
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MMP1,Interstitial collagenase,21623,76,1.41 [1.11-1.79],0.0047305091490048
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MN1,Transcriptional activator MN1,19029,66,1.37 [1.01-1.87],0.0462991938890195
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MRC1,Macrophage mannose receptor 1,19567,68,3.37 [1.71-6.64],0.0004309171640096
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MSR1,Macrophage scavenger receptor types I and II,22637,81,1.56 [1.02-2.39],0.0391261923473177
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MTUS1,Microtubule-associated tumor suppressor 1,19201,67,1.42 [1.00-1.99],0.0469068207956905
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,MVK,Mevalonate kinase,22021,77,1.33 [1.05-1.68],0.0193382096709161
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,19150,68,3.75 [1.40-10.04],0.0086302965951899
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NBN,Nibrin,22021,77,1.32 [1.01-1.71],0.0383677032908763
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,19459,66,2.20 [1.17-4.13],0.0144917645524924
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NDRG1,Protein NDRG1,21936,76,0.62 [0.40-0.97],0.0364568163277454
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NEFL,Neurofilament light polypeptide,21868,76,1.93 [1.35-2.76],0.0003447369569169
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NFASC,Neurofascin,22669,80,2.00 [1.03-3.87],0.0410766068405138
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NHLRC3,NHL repeat-containing protein 3,18661,67,2.75 [1.30-5.81],0.0081177168896717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NID1,Nidogen-1,22491,80,2.20 [1.35-3.57],0.001491914885696
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NOS3,"Nitric oxide synthase, endothelial",21936,76,1.47 [1.15-1.89],0.0024189116426902
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPC2,NPC intracellular cholesterol transporter 2,19226,67,1.84 [1.04-3.25],0.0363740657836362
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NPL,N-acetylneuraminate lyase,19554,67,1.74 [1.12-2.69],0.0131800394961944
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NRTN,Neurturin,22021,77,1.43 [1.04-1.96],0.0268472225707922
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NT5C1A,Cytosolic 5'-nucleotidase 1A,19518,67,1.75 [1.03-2.96],0.0390580168949145
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NT5E,5'-nucleotidase,22542,79,1.46 [1.07-2.01],0.0174566643002955
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTF3,Neurotrophin-3,22392,81,1.99 [1.30-3.04],0.0014263984105849
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NTproBNP,N-terminal prohormone of brain natriuretic peptide,22453,81,1.21 [1.03-1.41],0.0195280371474191
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,NUCB2,Nucleobindin-2,22588,81,1.75 [1.06-2.90],0.0291713515915394
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,OCLN,Occludin,19512,65,1.74 [1.09-2.78],0.0209402590495288
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PALM2,Paralemmin-2,19518,67,2.08 [1.25-3.47],0.0051288697931155
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,19121,68,1.98 [1.32-2.98],0.001034051757615
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PCDH9,Protocadherin-9,19459,66,2.40 [1.25-4.61],0.0085699275093298
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDIA3,Protein disulfide-isomerase A3,19150,68,2.36 [1.17-4.77],0.0167939105470709
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,18976,67,1.91 [1.25-2.89],0.0024814898118437
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,19150,68,1.98 [1.15-3.43],0.0141689375694566
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PIGR,Polymeric immunoglobulin receptor,22182,80,1.72 [1.03-2.89],0.0397487618478204
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PKD1,Polycystin-1,19554,67,2.44 [1.00-5.92],0.0497279368955026
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G15,Phospholipase A2 group XV,22542,79,2.62 [1.33-5.14],0.0052049561736242
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLA2G2A,"Phospholipase A2, membrane associated",22416,78,1.36 [1.03-1.80],0.0278275839658464
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PLXNB2,Plexin-B2,22617,79,2.64 [1.23-5.63],0.0122323380280997
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PODXL2,Podocalyxin-like protein 2,22542,79,1.97 [1.01-3.84],0.0477858884538641
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PREB,Prolactin regulatory element-binding protein,22021,77,1.96 [1.29-2.97],0.0016154919566451
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PSAP,Prosaposin,19374,68,2.50 [1.58-3.98],9.827205896099337e-05
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,18947,67,1.59 [1.02-2.47],0.039282217316037
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRB,Receptor-type tyrosine-protein phosphatase beta,19554,67,2.53 [1.16-5.48],0.0190547087278074
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTPRC,Receptor-type tyrosine-protein phosphatase C,19568,68,2.31 [1.01-5.29],0.0474696805974274
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTS,6-pyruvoyl tetrahydrobiopterin synthase,21826,76,1.68 [1.23-2.29],0.0009866476188279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,PTX3,Pentraxin-related protein PTX3,22392,81,1.80 [1.12-2.89],0.0146874093120286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,QPCT,Glutaminyl-peptide cyclotransferase,22510,78,2.27 [1.18-4.34],0.0134341210741814
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,18910,64,1.39 [1.05-1.83],0.019407440303049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RABEPK,Rab9 effector protein with kelch motifs,21953,75,1.38 [1.05-1.83],0.0229556602093156
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RALY,RNA-binding protein Raly,19460,68,1.45 [1.03-2.05],0.0336867008118445
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RARRES1,Retinoic acid receptor responder protein 1,21953,75,1.57 [1.07-2.31],0.0208706902068351
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBFOX3,RNA binding protein fox-1 homolog 3,19512,65,1.74 [1.14-2.65],0.01091984687717
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RBP5,Retinol-binding protein 5,22343,78,1.45 [1.04-2.02],0.0286661037729963
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RCC1,Regulator of chromosome condensation,19460,68,1.41 [1.01-1.97],0.0450861352817857
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,REST,RE1-silencing transcription factor,18853,65,1.74 [1.04-2.91],0.034878183503376
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,19201,67,1.33 [1.03-1.70],0.0264402505249049
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,19150,68,1.59 [1.05-2.41],0.0276702110563707
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RILP,Rab-interacting lysosomal protein,22558,80,1.43 [1.04-1.97],0.0277535839031174
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE1,Ribonuclease pancreatic,19567,68,2.21 [1.26-3.88],0.0058925222940178
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASE6,Ribonuclease K6,19424,67,1.86 [1.27-2.74],0.0016273923900105
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RNASET2,Ribonuclease T2,22640,78,2.05 [1.13-3.74],0.018713084343478
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,RTKN2,Rhotekin-2,18884,64,1.46 [1.09-1.96],0.0121747295608432
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,S100A3,Protein S100-A3,19460,68,0.41 [0.17-0.97],0.0424460485273027
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SAP18,Histone deacetylase complex subunit SAP18,19201,67,0.72 [0.52-0.99],0.0427849162688713
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCARB2,Lysosome membrane protein 2,21832,77,1.74 [1.02-2.96],0.0416778873014201
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCLY,Selenocysteine lyase,22558,80,2.00 [1.38-2.91],0.0002535700471255
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SCN2A,Sodium channel protein type 2 subunit alpha,18910,64,1.49 [1.05-2.10],0.0240255856137091
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SDC1,Syndecan-1,22453,81,1.66 [1.06-2.58],0.0252480556533008
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEMA7A,Semaphorin-7A,22666,79,1.94 [1.15-3.25],0.0126534566853992
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SERPINA11,Serpin A11,22732,79,1.65 [1.01-2.71],0.0472820504550886
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SETMAR,Histone-lysine N-methyltransferase SETMAR,22181,80,2.07 [1.22-3.51],0.0068595062321279
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SEZ6L2,Seizure 6-like protein 2,22343,78,2.19 [1.03-4.64],0.0410705527037618
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHISA5,Protein shisa-5,19568,68,1.94 [1.07-3.53],0.0290194468768959
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SHMT1,"Serine hydroxymethyltransferase, cytosolic",22511,81,1.26 [1.00-1.59],0.0477560300461258
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIAE,Sialate O-acetylesterase,22507,79,1.75 [1.16-2.63],0.0074187448297948
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC1,Sialoadhesin,22549,81,1.63 [1.05-2.52],0.0287550858887526
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC10,Sialic acid-binding Ig-like lectin 10,22392,81,1.75 [1.08-2.85],0.0236133606633882
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SIGLEC8,Sialic acid-binding Ig-like lectin 8,19070,67,1.66 [1.02-2.73],0.043081746976393
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLAMF1,Signaling lymphocytic activation molecule,22021,77,1.42 [1.01-1.98],0.0420483904603589
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLAMF6,SLAM family member 6,21953,75,1.69 [1.04-2.73],0.0323694683580324
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SLC16A1,Monocarboxylate transporter 1,21936,76,1.38 [1.06-1.79],0.0172466833984303
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNU13,NHP2-like protein 1,18884,64,0.55 [0.30-0.98],0.0423327567210612
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SNX5,Sorting nexin-5,19070,67,0.32 [0.12-0.84],0.0201287936648479
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SOD2,"Superoxide dismutase [Mn], mitochondrial",22481,80,1.74 [1.12-2.70],0.0136109558308121
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPINT2,Kunitz-type protease inhibitor 2,22549,81,1.72 [1.05-2.80],0.0303819131475103
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SPON1,Spondin-1,22479,81,1.70 [1.03-2.81],0.0397661072287982
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",22732,79,2.12 [1.38-3.25],0.0006219966407914
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,SULT2A1,Bile salt sulfotransferase,22392,81,1.35 [1.00-1.80],0.0467834465261286
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TEK,Angiopoietin-1 receptor,22542,79,3.61 [1.52-8.56],0.0036409873036645
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TEX33,Testis-expressed protein 33,19201,67,1.49 [1.07-2.06],0.0174628197436199
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFF1,Trefoil factor 1,22363,80,1.27 [1.03-1.57],0.0254116234730025
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFF2,Trefoil factor 2,22511,81,1.47 [1.08-2.00],0.0132734514930609
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFPI2,Tissue factor pathway inhibitor 2,22485,79,1.46 [1.09-1.94],0.010058639729665
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TFRC,Transferrin receptor protein 1,22561,80,1.71 [1.06-2.76],0.0291981428809179
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THBS2,Thrombospondin-2,22481,80,1.80 [1.15-2.83],0.0108472100411554
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THBS4,Thrombospondin-4,22491,80,1.57 [1.02-2.41],0.0395714796736485
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,THRAP3,Thyroid hormone receptor-associated protein 3,18884,64,1.22 [1.03-1.44],0.0181439307312171
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIE1,Tyrosine-protein kinase receptor Tie-1,22732,79,1.83 [1.01-3.34],0.0470851943313598
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TIMP1,Metalloproteinase inhibitor 1,22238,80,2.54 [1.45-4.44],0.001053377066851
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TJP3,Tight junction protein ZO-3,18910,64,1.54 [1.01-2.33],0.0429572158276979
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TK1,"Thymidine kinase, cytosolic",19201,67,0.52 [0.28-0.99],0.0463451804724697
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNC,Tenascin,22574,80,1.51 [1.02-2.25],0.0406529492505785
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNF,Tumor necrosis factor,22012,77,1.57 [1.14-2.16],0.0061513790352205
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,22257,80,1.67 [1.01-2.76],0.0460063757521337
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,22479,81,1.85 [1.30-2.64],0.0006538443583766
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,22481,80,1.53 [1.07-2.18],0.0184371582955207
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,22257,80,1.36 [1.00-1.85],0.0471383828702972
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TNFSF13,Tumor necrosis factor ligand superfamily member 13,22549,81,2.42 [1.22-4.82],0.0116952995024733
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPMT,Thiopurine S-methyltransferase,21953,75,1.30 [1.02-1.68],0.037481869496672
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,TPP1,Tripeptidyl-peptidase 1,22290,80,1.60 [1.15-2.24],0.0057326485150218
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,UPB1,Beta-ureidopropionase,19554,67,1.29 [1.01-1.64],0.0399291564068666
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VCAM1,Vascular cell adhesion protein 1,22527,80,2.62 [1.37-4.99],0.0034138683866257
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VCAN,Versican core protein,22637,81,1.89 [1.03-3.47],0.038707952845368
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VEGFA,Vascular endothelial growth factor A,22596,80,1.41 [1.03-1.93],0.0325606826625818
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VEGFC,Vascular endothelial growth factor C,22542,79,1.45 [1.02-2.07],0.0395239603837317
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VIM,Vimentin,22040,77,1.25 [1.03-1.52],0.0220228906728664
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,22040,77,1.32 [1.02-1.72],0.0346336454178735
"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,ZBTB17,Zinc finger and BTB domain-containing protein 17,22040,77,1.47 [1.04-2.07],0.0274275273324862
